SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Corixa [CRXA] - cancer vaccines -- Ignore unavailable to you. Want to Upgrade?

To: Micawber who wrote (85)6/21/2001 8:07:15 PM
From: Vector1  Read Replies (2) | Respond to of 222
 
Brian, sub-group analysis around a specific gene. This is not necessarily bad. The FDA likes it when they understand why something works or doesn't work. Remember Herceptin, DNA's revolutionary monoclonal anti-body for a sub group of woman with a certain type of breast cancer associated with the expression of a specific gene was approved and has been a sucessful drug.

V1


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News